Produção Nacional
Revisado por pares
Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned
2016; Informa; Volume: 15; Issue: 10 Linguagem: Inglês
10.1586/14760584.2016.1166961
ISSN1744-8395
AutoresLúcia Helena de Oliveira, Silas P. Trumbo, Cuauhtémoc Ruíz Matus, N. Jennifer Sanwogou, Cristiana M. Toscano,
Tópico(s)Pneumocystis jirovecii pneumonia detection and treatment
ResumoIn Latin America and the Caribbean, pneumococcus has been estimated to cause 12,000-28,000 deaths, 182,000 hospitalizations, and 1.4 million clinic visits annually. Countries in the Americas have been among the first developing nations to introduce pneumococcal conjugate vaccines into their Expanded Programs on Immunization, with 34 countries and territories having introduced these vaccines as of September 2015. Lessons learned for successful vaccine introduction include the importance of coordination between political and technical decision makers, adjustments to the cold chain prior to vaccine introduction, and the need for detailed plans addressing the financial and technical sustainability of introduction. Though many questions on the Pneumococcal Conjugate Vaccine remain unanswered, the experience of the Americas suggests that the vaccines can be introduced quickly and effectively.
Referência(s)